Psorinum

Product NDC: 44911-0097
11-digit product format: 449110097
Labeler code: 44911
Product ID: 44911-0097_0e27dae5-db51-4f1a-b12c-c3d8b3576a11
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Psorinum
Dosage form: LIQUID
Route: ORAL
Labeler: Energique, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2014-12-09
Marketing end: 2025-09-22
Substance: SCABIES LESION LYSATE (HUMAN)
Active strength: 7 [hp_X]/mL
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	44911-0097		D	Discontinued by firm		2026-08-03
excluded package	package	44911-0097	44911-0097-1	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 8 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	44911-0097-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	44911-0097-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	44911-0097-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	44911-0097-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
44911-0097-1	2021-12-28	C162847	48780-1	9d75b9d0-39d0-f424-e053-dadaa90a57ce	DRUG FACTS:
44911-0097-1	2020-01-31	C162847	48780-1	9d75b9d0-39d0-f424-e053-dadaa90a57ce	DRUG FACTS:

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SCABIES LESION LYSATE (HUMAN)	ACTIVE INGREDIENT	5UAU16Z1U4	PSORINUM LIQUID [ENERGIQUE, INC.]	1
SCABIES LESION LYSATE (HUMAN)	ACTIVE MOIETY	5UAU16Z1U4	PSORINUM LIQUID [ENERGIQUE, INC.]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	PSORINUM LIQUID [ENERGIQUE, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	PSORINUM LIQUID [ENERGIQUE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
44911-0097	PSORINUM LIQUID [ENERGIQUE, INC.]	2	Legacy NDC	20211229_fe712217-e56d-49f7-a791-0351f5e61896.zip

UNII, Preferred term, Matched term table
UNII	Preferred term	Matched term
5UAU16Z1U4	SCABIES LESION LYSATE (HUMAN)	SCABIES LESION LYSATE (HUMAN)

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
44911-0097-1	44911009701	30 mL in 1 PACKAGE (44911-0097-1)	30 ml	2014-12-09	2025-09-22	No	No	Current